CA2251060A1 - Promedicaments acyles de la n-hydroxymethylthalidomide a effet immunomodulateur - Google Patents

Promedicaments acyles de la n-hydroxymethylthalidomide a effet immunomodulateur

Info

Publication number
CA2251060A1
CA2251060A1 CA002251060A CA2251060A CA2251060A1 CA 2251060 A1 CA2251060 A1 CA 2251060A1 CA 002251060 A CA002251060 A CA 002251060A CA 2251060 A CA2251060 A CA 2251060A CA 2251060 A1 CA2251060 A1 CA 2251060A1
Authority
CA
Canada
Prior art keywords
acylated
prodrugs
hydroxy methyl
immunomodulator
action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002251060A
Other languages
English (en)
Other versions
CA2251060C (fr
Inventor
Johannes Schneider
Werner Winter
Stephan Wnendt
Kai Zwingenberger
Kurt Eger
Michaela Akermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Grunenthal Gmbh
Johannes Schneider
Werner Winter
Stephan Wnendt
Kai Zwingenberger
Kurt Eger
Michaela Akermann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19613976A external-priority patent/DE19613976C1/de
Application filed by Grunenthal Gmbh, Johannes Schneider, Werner Winter, Stephan Wnendt, Kai Zwingenberger, Kurt Eger, Michaela Akermann filed Critical Grunenthal Gmbh
Publication of CA2251060A1 publication Critical patent/CA2251060A1/fr
Application granted granted Critical
Publication of CA2251060C publication Critical patent/CA2251060C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002251060A 1996-04-09 1997-03-22 Promedicaments acyles de la n-hydroxymethylthalidomide a effet immunomodulateur Expired - Fee Related CA2251060C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19613976.7 1996-04-09
DE19613976A DE19613976C1 (de) 1996-04-09 1996-04-09 Thalidomid-Prodrugs mit immunmodulatorischer Wirkung
PCT/EP1997/001475 WO1997037988A1 (fr) 1996-04-09 1997-03-22 Promedicaments acyles de la n-hydroxymethylthalidomide a effet immunomodulateur

Publications (2)

Publication Number Publication Date
CA2251060A1 true CA2251060A1 (fr) 1997-10-16
CA2251060C CA2251060C (fr) 2006-09-12

Family

ID=36999576

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002251060A Expired - Fee Related CA2251060C (fr) 1996-04-09 1997-03-22 Promedicaments acyles de la n-hydroxymethylthalidomide a effet immunomodulateur

Country Status (1)

Country Link
CA (1) CA2251060C (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7320991B2 (en) 2001-02-27 2008-01-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, National Institutes Of Health Analogs of thalidomide as potential angiogenesis inhibitors
US7973057B2 (en) 2003-09-17 2011-07-05 The United States Of America As Represented By The Department Of Health And Human Services Thalidomide analogs
US8853253B2 (en) 2003-09-17 2014-10-07 P2D, Inc. Thalidomide analogs
US9084783B2 (en) 2011-12-02 2015-07-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thio compounds

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7320991B2 (en) 2001-02-27 2008-01-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, National Institutes Of Health Analogs of thalidomide as potential angiogenesis inhibitors
US8716315B2 (en) 2001-02-27 2014-05-06 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Analogs of thalidomide as potential angiogenesis inhibitors
US7973057B2 (en) 2003-09-17 2011-07-05 The United States Of America As Represented By The Department Of Health And Human Services Thalidomide analogs
US8546430B2 (en) 2003-09-17 2013-10-01 P2D, Inc. Thalidomide analogs
US8853253B2 (en) 2003-09-17 2014-10-07 P2D, Inc. Thalidomide analogs
US9084783B2 (en) 2011-12-02 2015-07-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thio compounds
US9623020B2 (en) 2011-12-02 2017-04-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thio compounds
US10220028B2 (en) 2011-12-02 2019-03-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thio compounds

Also Published As

Publication number Publication date
CA2251060C (fr) 2006-09-12

Similar Documents

Publication Publication Date Title
AU2505297A (en) Acylated N-hydroxymethyl thalidomide prodrugs having an immunomodulatory effect
ATE136027T1 (de) Therapeutische amide
WO2000046199A3 (fr) Composes chimiques
YU9301A (sh) Peptidi kao inhibitori hepatitisa c
IL129555A (en) Pharmaceutical compositions containing n-(oxoacetyl)-amino acid amide derivatives for stimulating neurite growth
NO159017C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,2,3,4-tetrahydroisokinolin-3-karboksylsyre-derivater.
GEP20012413B (en) Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents
TW262468B (fr)
GR3032311T3 (en) Stilbene derivatives and pharmaceutical compositions containing them
CY1107391T1 (el) Αρυλσυμπυκνωμενες αζαπολυκυκλικες ενωσεις
MC2195A1 (fr) Derives d'acides amines
CA2373117A1 (fr) Derives de 13-methyl-erythromycine
YU5893A (sh) Sulfonilkarbamid i postupak za njegovo dobijanje
CA2251060A1 (fr) Promedicaments acyles de la n-hydroxymethylthalidomide a effet immunomodulateur
NO900342D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-fenyl-5,6-dihydrobenz(c)acridin-7-carboxylsyrer og beslektede forbindelser.
ATE101126T1 (de) Amide von cyclomethylen-1,2 bicarbonsaeure mit therapeutischer wirkung, verfahren zu deren herstellung sowie diese enthaltende pharmazeutische zusammensetzungen.
IL93594A0 (en) Pharmaceutical compositions containing an imidazopyrimidone derivative
GR871549B (en) Amino acid derivative anticonvulsant
ATE210985T1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen
HUP9903414A2 (en) 3-alkoxypyridine-2-carboxylic acid amide esters,their preparation and their use as drugs
HU208308B (en) Process for producing acylated amino acid derivatives and pharmaceutical compositions comprising same as active ingredient

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed